
Fat profit: Mounjaro sales top ₹150 Cr in August; Wegovy marks 3x jump
New Delhi: The strive of slimming waistlines is bringing big gains for pharma giants in India, as blockbuster brand Mounjaro has racked up Rs 154 crore in six months of its launch, while its arch rival Wegovy is closing the gap with nearly a three-fold …